Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma	Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease	Active, not recruiting	Phase 1	2026-10-05		NCT02291848

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Baylor College of Medicine	267
Center for Cell and Gene Therapy, Baylor College of Medicine	40
Harris County Hospital District	2
The Methodist Hospital Research Institute	124

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Harris Health Ben Taub Hospital	Houston	United States	1
Harris Health Smith Clinic	Houston	United States	1
Houston Methodist Hospital	Houston	United States	260